Safety and Immunogenicity of Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine: A Randomized Trial in 10-25-Year-Old HIV-Seronegative African Girls and Young Women.

Sow PS, Watson-Jones D, Kiviat N, Changalucha J, Mbaye JD, Brown J, Bousso K, Kavishe B, Andreasen A, Toure M, Kapiga S, Mayaud P, Hayes R, Lebacq M, Herazeh M, Thomas F, Descamps D.

J Infect Dis 2013; 207:1753-63.

PMID:23242542

PMCID:PMC3636781

DOI:10.1093/infdis/jis619

Related citation